MIAMI, FL — April 22, 2025 — IAOCR (International Accrediting Organization for Clinical Research) and GCSA (Global Clinical Site Assessment), the world’s leading clinical research accreditation bodies, today announced the official launch of their certification programs in Latin America. Supported by the new regional hub at https://iaocramericas.com/, this expansion empowers Latin American clinical research stakeholders to achieve globally recognized standards of excellence, reduce trial risk, and attract international sponsors.
For the first time, clinical trial sites, professionals, and organizations in Latin America can access IAOCR’s UNESCO-aligned certifications and GCSA’s patient-centric site assessments—tools already trusted by regulators, sponsors, and CROs in 40+ countries. The launch addresses critical regional challenges, including:
“Latin America is poised to become a clinical research powerhouse, with cancer trial participation alone projected to grow by 66% by 2040,” said Julio G. Martínez, President of IAOCR/GCSA Americas. “By bringing IAOCR/GCSA’s gold-standard certifications to the region, we’re equipping sites and professionals to meet global benchmarks, ensuring safer trials, faster approvals, and stronger partnerships with international sponsors.”
IAOCR/GCSA Americas has partnered with leading organizations to drive adoption, including:
The launch coincides with the debut of https://iaocramericas.com/, providing Spanish/Portuguese resources for:
“Latin America’s clinical research potential is immense but underleveraged,” said Jacqueline Johnson, IAOCR Global CEO. “With Julio’s leadership and IAOCR/GCSA’s rigorous standards, the region will play a pivotal role in delivering tomorrow’s treatments.”
About IAOCR/GCSA
IAOCR is the world-leader in clinical research accreditation, with standards endorsed by UNESCO and regulators worldwide. GCSA (Global Clinical Site Assessment) certifies clinical trial sites against evidence-based operational benchmarks. Together, they reduce risk, enhance compliance, and accelerate timelines for 1,000+ organizations globally.